Work

Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China

Year: 2023
Type: article
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4388680604
FWCI: 2.66
Cites: 30
Cited by: 16
Related to: 10